Kaelgemvax received European patent of malaria vaccine
Domestic biotech company Kaelgemvax, announced that they received European patent of malaria vaccine. This patent will be notified on June 4, 2014 to the European Patent Office (EPO). (Patent Number: EP1, 569,950)
This malaria vaccine patent is for the treatment and prevention of malaria induced...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
